Current and future considerations for the use of immune checkpoint inhibitors in NSCLC
Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives.
The expert
Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchONCOLOGY
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.